# Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

> **NCT01372774** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 194 (actual)

## Conditions studied

- Cognitive/Functional Effects
- Metastatic Cancer
- Neurotoxicity
- Radiation Toxicity
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **RADIATION:** stereotactic radiosurgery
- **RADIATION:** whole-brain radiation therapy

## Key facts

- **NCT ID:** NCT01372774
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2016-08
- **Final completion:** 2019-12-15
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2022-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372774, "Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01372774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*